Oncologic outcomes in patients treated with endoscopic robot assisted simple enucleation (ERASE) for renal cell carcinoma: Results from a tertiary referral center
ConclusionsERASE is a safe procedure, achieving negative surgical margins in the vast majority of patients and providing excellent mid-term local control and oncologic outcomes.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Coccidioidomycosis (Valley Fever) | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Study | Surgery | Urology & Nephrology